FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer.
Li QiuLinfei HuHuijuan WangJinling LiXianhui RuanBingsheng SunJingtai ZhiXiangqian ZhengLin GuMing GaoPengzhou KongJun ZhangPublished in: Cell death & disease (2020)
Polyamine biosynthesis is an essential metabolic pathway for cell growth and differentiation in non-small-cell lung cancer (NSCLC). Fragile-site associated tumour suppressor (FATS) is a novel gene involved in cancer. The results of our previous study showed that FATS-mediated polyubiquitination of p53 promotes the activation of p53 in response to DNA damage; however, little is known about the role of FATS in metabolic reprogramming in NSCLC. In the present study, FATS was observed to be significantly downregulated in NSCLC tissues compared with paired adjacent normal tissues and was associated with the survival of NSCLC patients. We further showed that the presence of the tumour suppressor FATS in NSCLC cells led to apoptosis by inducing pro-death autophagy. In addition, FATS was shown to function as a suppressor of polyamine biosynthesis by inhibiting ornithine decarboxylase (ODC) at the protein and mRNA levels, which was partially dependent on oestrogen receptor (ER). Furthermore, FATS was observed to bind to ERβ and translocate to the cytosol, leading to ODC degradation. The findings of our study demonstrate that FATS plays important roles in polyamine metabolism in NSCLC and provides a new perspective for NSCLC progression.
Keyphrases
- small cell lung cancer
- advanced non small cell lung cancer
- dna damage
- oxidative stress
- endoplasmic reticulum stress
- brain metastases
- gene expression
- ejection fraction
- induced apoptosis
- squamous cell carcinoma
- newly diagnosed
- breast cancer cells
- end stage renal disease
- young adults
- small molecule
- dna repair
- endoplasmic reticulum
- patient reported outcomes
- peritoneal dialysis
- anti inflammatory